Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOSA: Oxygen Therapy in Children With Down Syndrome and OSA
NCT06043440Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Oct 2023
- Primary completion
- Nov 2027
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of oxygen in obstructive sleep apnea (OSA), sponsored by Brigham and Women's Hospital. Started Oct 2023; status: recruiting.
02
Drugs
oxygen
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06043440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06043440.